Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |